ENHANCEMENT OF THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PRETREATMENT WITH HEPARIN

被引:132
作者
CERCEK, B [1 ]
LEW, AS [1 ]
HOD, H [1 ]
YANO, J [1 ]
REDDY, NKN [1 ]
GANZ, W [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024
关键词
D O I
10.1161/01.CIR.74.3.583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:583 / 587
页数:5
相关论文
共 27 条
  • [21] MARCKWARDT F, 1977, HAEMOSTASIS, V6, P370
  • [22] MARSHALL ROBERT, 1963, THORAX, V18, P1, DOI 10.1136/thx.18.1.1
  • [23] SULFITE PRECIPITATION METHOD FOR FIBRINOGEN MEASUREMENT - USE ON SMALL SAMPLES IN PRESENCE OF FIBRINOGEN DEGRADATION PRODUCTS
    RAMPLING, MW
    GAFFNEY, PJ
    [J]. CLINICA CHIMICA ACTA, 1976, 67 (01) : 43 - 52
  • [24] RELATIONSHIP OF THE LYTIC STATE TO SUCCESSFUL REPERFUSION WITH STANDARD-DOSE AND LOW-DOSE INTRACORONARY STREPTOKINASE
    ROTHBARD, RL
    FITZPATRICK, PG
    FRANCIS, CW
    CATON, DM
    HOOD, WB
    MARDER, VJ
    [J]. CIRCULATION, 1985, 71 (03) : 562 - 570
  • [25] CONTINUED INCORPORATION OF CIRCULATING RADIOLABELED FIBRINOGEN INTO PREFORMED CORONARY-ARTERY THROMBI
    SALIMI, A
    OLIVER, GC
    LEE, J
    SHERMAN, LA
    [J]. CIRCULATION, 1977, 56 (02) : 213 - 217
  • [26] CORONARY THROMBOLYSIS WITH INTRAVENOUSLY ADMINISTERED HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR PRODUCED BY RECOMBINANT DNA TECHNOLOGY
    VANDEWERF, F
    BERGMANN, SR
    FOX, KAA
    DEGEEST, H
    HOYNG, CF
    SOBEL, BE
    COLLEN, D
    [J]. CIRCULATION, 1984, 69 (03) : 605 - 610
  • [27] SYSTEMIC MARKERS OF FIBRINOLYSIS AFTER UNSUCCESSFUL INTRACORONARY STREPTOKINASE THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - DOES NONREPERFUSION INDICATE FAILURE TO ACHIEVE A SYSTEMIC LYTIC STATE
    WHITE, CW
    SCHWARTZ, JL
    FERGUSON, DW
    BRAYDEN, GP
    KELLY, KJ
    KIOSCHOS, JM
    MARCUS, ML
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) : 712 - 717